WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2009141238) GPR119 RECEPTOR AGONISTS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2009/141238    International Application No.:    PCT/EP2009/055644
Publication Date: 26.11.2009 International Filing Date: 11.05.2009
Chapter 2 Demand Filed:    11.12.2009    
IPC:
C07D 487/04 (2006.01), A61K 31/519 (2006.01), A61P 3/10 (2006.01)
Applicants: F. HOFFMANN-LA ROCHE AG [CH/CH]; Grenzacherstrasse 124 CH-4070 Basel (CH) (For All Designated States Except US).
ERICKSON, Shawn David [US/US]; (US) (For US Only).
GILLESPIE, Paul [GB/US]; (US) (For US Only).
GUERTIN, Kevin Richard [US/US]; (US) (For US Only).
KARNACHI, Prabha Saba [US/US]; (US) (For US Only).
KIM, Kyungjin [KR/US]; (US) (For US Only).
MA, Chun [CN/US]; (US) (For US Only).
MC COMAS, Warren William [US/US]; (US) (For US Only).
PIETRANICO-COLE, Sherrie Lynn [US/US]; (US) (For US Only).
QI, Lida [US/US]; (US) (For US Only).
TILLEY, Jefferson Wright [US/US]; (US) (For US Only).
ZHANG, Qiang [CN/US]; (US) (For US Only)
Inventors: ERICKSON, Shawn David; (US).
GILLESPIE, Paul; (US).
GUERTIN, Kevin Richard; (US).
KARNACHI, Prabha Saba; (US).
KIM, Kyungjin; (US).
MA, Chun; (US).
MC COMAS, Warren William; (US).
PIETRANICO-COLE, Sherrie Lynn; (US).
QI, Lida; (US).
TILLEY, Jefferson Wright; (US).
ZHANG, Qiang; (US)
Agent: WASCHBUESCH, Klaus; Grenzacherstrasse 124 CH-4070 Basel (CH)
Priority Data:
61/054,227 19.05.2008 US
Title (EN) GPR119 RECEPTOR AGONISTS
(FR) AGONISTES DES RÉCEPTEURS DE GPR119
Abstract: front page image
(EN)Provided herein are compounds of the formula (I): as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of metabolic diseases and disorders such as, for example, type II diabetes mellitus.
(FR)L'invention porte sur des composés de la formule (I) : ainsi que sur des sels pharmaceutiquement acceptables de ceux-ci, les substituants étant ceux indiqués dans la description. Ces composés, et les compositions pharmaceutiques les contenant, sont utiles pour le traitement de maladies et troubles métaboliques, tels que, par exemple, le diabète sucré de type II.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)